Literature DB >> 16500684

Chemical modifiers of unstable expanded simple sequence repeats: what goes up, could come down.

Mário Gomes-Pereira1, Darren G Monckton.   

Abstract

A mounting number of inherited human disorders, including Huntington disease, myotonic dystrophy, fragile X syndrome, Friedreich ataxia and several spinocerebellar ataxias, have been associated with the expansion of unstable simple sequence DNA repeats. Despite a similar genetic basis, pathogenesis in these disorders is mediated by a variety of both loss and gain of function pathways. Thus, therapies targeted at downstream pathology are likely to be disease specific. Characteristically, disease-associated expanded alleles in these disorders are highly unstable in the germline and somatic cells, with a tendency towards further expansion. Whereas germline expansion accounts for the phenomenon of anticipation, tissue-specific, age-dependent somatic expansion may contribute towards the tissue-specificity and progressive nature of the symptoms. Thus, somatic expansion presents as a novel therapeutic target in these disorders. Suppression of somatic expansion should be therapeutically beneficial, whilst reductions in repeat length could be curative. It is well established that both cis- and trans-acting genetic modifiers play key roles in the control of repeat dynamics. Importantly, recent data have revealed that expanded CAG.CTG repeats are also sensitive to a variety of trans-acting chemical modifiers. These data provide an exciting proof of principle that drug induced suppression of somatic expansion might indeed be feasible. Moreover, as our understanding of the mechanism of expansion is refined more rational approaches to chemical intervention in the expansion pathway can be envisioned. For instance, the demonstration that expansion of CAG.CTG repeats is dependent on the Msh2, Msh3 and Pms2 genes, highlights components of the DNA mismatch repair pathway as therapeutic targets. In addition to potential therapeutic applications, the response of expanded simple repeats to genotoxic assault suggests such sequences could also have utility as bio-monitors of environmentally induced genetic damage in the soma.

Entities:  

Mesh:

Year:  2006        PMID: 16500684     DOI: 10.1016/j.mrfmmm.2006.01.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  35 in total

1.  New insights into repeat instability: role of RNA•DNA hybrids.

Authors:  Elizabeth I McIvor; Urszula Polak; Marek Napierala
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location.

Authors:  Carole Yauk; Aris Polyzos; Andrea Rowan-Carroll; Christopher M Somers; Roger W Godschalk; Frederik J Van Schooten; M Lynn Berndt; Igor P Pogribny; Igor Koturbash; Andrew Williams; George R Douglas; Olga Kovalchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

3.  Chemical reversal of the RNA gain of function in myotonic dystrophy.

Authors:  Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

Review 4.  Therapeutics development in myotonic dystrophy type 1.

Authors:  Erin Pennock Foff; Mani S Mahadevan
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

Review 5.  Myotonic dystrophy mouse models: towards rational therapy development.

Authors:  Mário Gomes-Pereira; Thomas A Cooper; Geneviève Gourdon
Journal:  Trends Mol Med       Date:  2011-07-02       Impact factor: 11.951

Review 6.  Expanded complexity of unstable repeat diseases.

Authors:  Urszula Polak; Elizabeth McIvor; Sharon Y R Dent; Robert D Wells; Marek Napierala
Journal:  Biofactors       Date:  2012-12-11       Impact factor: 6.113

7.  Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.

Authors:  Chun-Ho Wong; Stacie L Richardson; Yen-Jun Ho; Alex M H Lucas; Tiziano Tuccinardi; Anne M Baranger; Steven C Zimmerman
Journal:  Chembiochem       Date:  2012-10-24       Impact factor: 3.164

8.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

9.  DNA instability in replicating Huntington's disease lymphoblasts.

Authors:  Milena Cannella; Vittorio Maglione; Tiziana Martino; Giuseppe Ragona; Luigi Frati; Guo-Min Li; Ferdinando Squitieri
Journal:  BMC Med Genet       Date:  2009-02-11       Impact factor: 2.103

10.  Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.

Authors:  Beatriz Llamusí; Ruben Artero
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.